Xavier Saelens
scientist
medical science
Flanders Interuniversity Institute for Biotechnology
Belgium
Biography
​PhD: Univ. of Ghent, Ghent, Belgium, 1990 Postdoc: Univ. of Ghent, Ghent, Belgium, 1990-2004 VIB Project Leader since 2005 VIB Expert Scientist since 2009 VIB Group leader as of January 2015
Research Interest
Inflammation and immunity Microbiology
Publications
-
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein Schepens B, Sedeyn K, Vande Ginste L, De Baets S, Schotsaert M, Roose K, Houspie L, Van Ranst M, Gilbert B, Van Rooijen N, Fiers W, Piedra P, Saelens XEMBO Molecular Medicine, 6, 1436-54, 2014
-
Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses Verhelst J, Spitaels J, Nurnberger C, De Vlieger D, Ysenbaert T, Staeheli P, Fiers W, Saelens XJOURNAL OF VIROLOGY, 89, 10879-90, 2015
-
GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation Naessens T, Schepens B, Smet M, Pollard C, Van Hoecke L, De Beuckelaer A, Willart M, Lambrecht B, De Koker S, Saelens X, Grooten JJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 137, 700-709 e9, 2016
